The Global Point-of-Care Molecular Diagnostics Market is projected to grow at a CAGR of 10.2% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals ...
The "Molecular Diagnostics for Cancer – Markets, Strategies and Trends. Forecasts by Cancer Type, Including Companion Dx and by Country with Executive and Consultant Guides and COVID-19 Pandemic ...
Clinical Utility of Pharmacogenomics and Genetic Testing Remains an Issue Through rapid advances in research and clinical applications, molecular diagnostics has grown from a genomic and proteomic ...
(Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular diagnostic tests, today announced that it has engaged Maxim Group ...
BillionToOne, Inc (NASDAQ: BLLN) IPO will take place November, 06 on the NASDAQ exchange under the ticker BLLN. The company is offering shares at an expected price between $49.00 and $55.00 per share ...
Molecular diagnostics firm BillionToOne raised $273.1 million in its U.S. initial public offering on Wednesday, pricing its shares above its marketed range. The Menlo Park, California-based company ...
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...
Sciverse Solutions and Bhat Biotech forge strategic collaboration for next-generation molecular diagnostics: Our Bureau, Bengaluru Thursday, November 6, 2025, 16:45 Hrs [IST] Sciv ...
SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, and inflammatory and infectious diseases, today announced it has been ...
The government shutdown has slowed down the IPO market. But the fact that the Securities and Exchange Commission’s operations have been curtailed while Washington is essentially in dark mode hasn’t ...
BillionToOne Inc., a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering, during a US government shutdown that has complicated the listing process.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback